Oncology Diagnostics Liaison: Biomarker Pathways

AstraZeneca plc; Greater London; On-site; GBP 70,000 - 95,000; Full time

Job summary

AstraZeneca plc seeks a Diagnostic Liaison to accelerate testing and diagnosis in solid tumours across London and the South East. You will build partnerships with NHS/private labs, enable guideline-aligned testing, and support HCP decision-making within AstraZeneca’s oncology portfolio.

The role focuses on pathway optimisation, biomarker excellence, education, and cross-functional execution, with travel across the region as needed for collaboration and implementation.

Qualifications

• Undergraduate degree in life sciences or biomedical discipline.
• Experience in diagnostics or clinical testing in solid tumours.
• Broad knowledge of UK solid tumour diagnostic pathways and biomarkers.
• Hands-on understanding of histopathology workflows and molecular techniques.
• Ability to engage laboratory leadership and clinical teams.
• Strong communication skills and ability to present technical data.
• Cross-functional collaboration and project execution.
• Willingness to travel across London and the South East.

Responsibilities

• Engage ecosystem and develop strategic relationships across oncology diagnostic pathways.
• Diagnose bottlenecks and co-create solutions for test adoption and process improvements.
• Drive biomarker awareness and appropriate use across AstraZeneca’s oncology portfolio.
• Deliver non-promotional educational programs on testing standards and QA.
• Gather field insights to inform portfolio, brand and diagnostic strategy.

Skills

Oncology diagnostics

Stakeholder engagement

Communication skills

Cross-functional collaboration

Travel willingness

Education

Undergraduate life science degree

Job description

AstraZeneca plc seeks a Diagnostic Liaison to accelerate testing and diagnosis in solid tumours across London and the South East. You will build partnerships with NHS/private labs, enable guideline-aligned testing, and support HCP decision-making within AstraZeneca’s oncology portfolio.

The role focuses on pathway optimisation, biomarker excellence, education, and cross-functional execution, with travel across the region as needed for collaboration and implementation.